FDA Approves the Reformulation Of Abuse-Resistant OxyContin

摘要

The FDA has approved Purdue Pharma's reformulation of its painkiller OxyContin controlled-re-lease tablets, designed to be tamper-resistant to prevent misuse and abuse of the opioid medication.rnThe agency's approval follows an overwhelming recommendation last September from two advisory committees to approve the new formulation, which includes changes to the drug's chemical and physical properties.